Status:
RECRUITING
Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
Lead Sponsor:
University Hospital, Tours
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. In...
Eligibility Criteria
Inclusion Criteria:
-
Age between 18 and 65 years
-
Patient with a diagnosed and reported schizophrenic disorder announced :
- Schizophrenia
- Schizoaffective disorder
-
Or a diagnosed and reported Delusional Disorder
-
Express written consent by the participant after receiving information about the study
-
Be able to communicate verbally
-
Participant affiliated to a social security scheme
Exclusion Criteria:
- Pregnant or breastfeeding woman
- Patient who does not speak French
- Participation in a psycho-education group in the last 2 years
- Patient under legal protection or guardianship
Key Trial Info
Start Date :
June 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05329363
Start Date
June 17 2022
End Date
June 1 2027
Last Update
April 23 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Serrvice de Psychiatrie
Blois, France
2
Service de psychiatrie
Chinon, France
3
Service de psychiatrie
Dreux, France
4
Service de psychiatrie
Fleury-les-Aubrais, France